Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Teradata Corp
TDC
5
Hutchmed (China)
HCM
US Stock MarketDetailed Quotes
VRDN Viridian Therapeutics
- 13.450
- -0.060-0.44%
Trading Apr 24 12:29 ET
1.10BMarket Cap-4.38P/E (TTM)
13.680High13.410Low121.86KVolume13.490Open13.510Pre Close1.64MTurnover0.17%Turnover RatioLossP/E (Static)81.48MShares27.20052wk High2.27P/B976.87MFloat Cap9.90052wk Low--Dividend TTM72.63MShs Float2247.750Historical High--Div YieldTTM2.00%Amplitude4.665Historical Low13.496Avg Price1Lot Size
About Viridian Therapeutics Company
Viridian Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product candidates include Cobomarsen, which treats patients with certain cancers, including cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma, and Remlarsen and MRG-229, which are made for the treatment of patients with pathological fibrosis. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.
Company Profile
SymbolVRDN
Company NameViridian Therapeutics
Listing DateJun 18, 2014
Issue Price10.00
Founded2006
CEOMr. Stephen Mahoney
MarketNASDAQ
Employees143
Fiscal Year Ends12-31
Address221 Crescent Street,Suite 401
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02453
Phone1-617-272-4600
Company Executives
- Name
- Position
- Salary
- Stephen Mahoney
- President, Chief Executive Officer and Director
- 12.48M
- Dr. Thomas Ciulla
- Chief Medical Officer
- --
- Jennifer Tousignant
- Chief Legal Officer
- --
- Thomas W. Beetham
- Chief Operating Officer
- 4.76M
- Seth Harmon
- Chief Financial Officer and Principal Accounting Officer
- 6.55M
- Tomas Kiselak
- Chairman of the Board
- 503.83K
- Dr. Christopher Cain, PhD
- Director
- --
- Jeffrey R. Ajer
- Director
- --
- Jennifer K. Moses
- Independent Director
- 467.83K
- Arlene M. Morris
- Independent Director
- 477.83K
- Dr. Sarah Gheuens, M.D.,PhD
- Independent Director
- 482.53K
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now